Austrian Registry on Transjugular Intrahepatic Portosystemic Shunts
AUTIPS
Österreichisches Register (inklusive Biobank) Für Transjuguläre Intrahepatische Portosystemischem Shunts (TIPS): AUTIPS (AUstrian TIPS Study)
1 other identifier
observational
400
1 country
1
Brief Summary
Patients with TIPS will be recruited in this prospective registry study. The clinical course will be documented and biomarkers for prediction of complicatiosn will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2018
CompletedFirst Posted
Study publicly available on registry
January 24, 2018
CompletedStudy Start
First participant enrolled
March 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
November 6, 2024
November 1, 2024
9.8 years
January 18, 2018
November 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Transplant-free survival
Assessment of transplant-free survival after TIPS implantation
0-10 years
Secondary Outcomes (4)
Assessment of portalhypertensive complications
0-10 years
Assessment of hepatic encephalopathy
0-10 years
Assessment of Patient Reported Quality of Life (SF36v2)
0-10 years
Assessment of Patient Reported Quality of Life (CLDQ)
0-10 years
Interventions
Not applicable (observational registry study)
Eligibility Criteria
Inpatients or outpatients who are scheduled for TIPS implantation, or who have recently undergone TIPS implantation and are visiting outpatienc clinics for control visits/surveillance
You may qualify if:
- Age 18-99 years
- Portal hypertension
- Anticipated or past implantation of a transjugular intrahepatic portosystemic shunt (TIPS)
- Informed consent
You may not qualify if:
- Retraction of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Vienna
Vienna, Vienna, 1090, Austria
Biospecimen
Blood samples (collected during routine blood draws): chemistry, hematology, coagulation panel Ascites: WBC, PMN, protein Urine assessment: RBC, protein, sediment
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Reiberger, MD
Medical University of Vienna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Univ. Prof. Priv.-Doz. Dr.
Study Record Dates
First Submitted
January 18, 2018
First Posted
January 24, 2018
Study Start
March 28, 2018
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
November 6, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data may not be shared publicly due to local data safety regulations. Please contact the sponsor for more information.